ZA201409124B - Reassortant btv and ahsv vaccines - Google Patents
Reassortant btv and ahsv vaccinesInfo
- Publication number
- ZA201409124B ZA201409124B ZA2014/09124A ZA201409124A ZA201409124B ZA 201409124 B ZA201409124 B ZA 201409124B ZA 2014/09124 A ZA2014/09124 A ZA 2014/09124A ZA 201409124 A ZA201409124 A ZA 201409124A ZA 201409124 B ZA201409124 B ZA 201409124B
- Authority
- ZA
- South Africa
- Prior art keywords
- ahsv
- vaccines
- reassortant btv
- btv
- reassortant
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12171—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261659198P | 2012-06-13 | 2012-06-13 | |
| PCT/US2013/045667 WO2013188673A2 (en) | 2012-06-13 | 2013-06-13 | Reassortant btv and ahsv vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201409124B true ZA201409124B (en) | 2017-05-31 |
Family
ID=49237584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2014/09124A ZA201409124B (en) | 2012-06-13 | 2014-12-11 | Reassortant btv and ahsv vaccines |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10801039B2 (en) |
| EP (1) | EP2861248B1 (en) |
| JP (1) | JP6347257B2 (en) |
| KR (1) | KR102136437B1 (en) |
| CN (2) | CN104582724A (en) |
| AU (2) | AU2013274191B2 (en) |
| BR (1) | BR112014031133B1 (en) |
| CA (1) | CA2876196C (en) |
| ES (1) | ES2664069T3 (en) |
| HK (1) | HK1209326A1 (en) |
| IL (1) | IL236148B (en) |
| MA (1) | MA37749B1 (en) |
| MX (1) | MX364875B (en) |
| NZ (1) | NZ703297A (en) |
| RU (1) | RU2656187C2 (en) |
| TN (1) | TN2014000518A1 (en) |
| WO (1) | WO2013188673A2 (en) |
| ZA (1) | ZA201409124B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11053509B2 (en) | 2016-04-19 | 2021-07-06 | Csir | Plant-produced chimaeric Orbivirus VLPs |
| CN109312351B9 (en) | 2016-04-26 | 2020-10-23 | 伦敦卫生及热带医学学院 | Reoviridae vaccines |
| CN110049994B (en) * | 2016-12-08 | 2023-05-02 | 拜西欧斯（北京）生物技术有限公司 | Conjugate and application thereof |
| CN109897092B (en) * | 2019-04-02 | 2019-11-19 | 深圳海关动植物检验检疫技术中心 | A kind of solvable preparation method of blue tongue virus NS3 gene |
| CN110016466B (en) * | 2019-05-21 | 2022-09-13 | 云南省畜牧兽医科学院 | Monoclonal antibody for specifically detecting bluetongue virus, hybridoma cell strain and application thereof |
| CN110257560B (en) * | 2019-07-23 | 2023-06-27 | 深圳海关动植物检验检疫技术中心 | Reagent for bluetongue virus type 8 detection, detection method and application |
| CN112375848A (en) * | 2020-12-11 | 2021-02-19 | 云南省畜牧兽医科学院 | RT-qPCR detection kit and method for identifying bluetongue virus serotype |
| CN116024183B (en) * | 2023-02-15 | 2023-10-31 | 中国农业科学院兰州兽医研究所 | Recombinant bluetongue virus for fluorescent staining and construction method thereof |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| CA1247080A (en) | 1983-03-08 | 1988-12-20 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| DE3584341D1 (en) | 1984-08-24 | 1991-11-14 | Upjohn Co | RECOMBINANT DNA COMPOUNDS AND EXPRESSION OF POLYPEPTIDES LIKE TPA. |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4963481A (en) | 1985-12-18 | 1990-10-16 | Genetics Institute Inc | Promoter system |
| US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| DK175363B1 (en) | 1986-09-12 | 2004-09-13 | Genentech Inc | Process for Continuous Production of a Desired Heterologous Protein in a Eukaryotic Host Cell, Vector Adding That Ability, and Cells Transformed with the Vector |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| DE3743138A1 (en) | 1987-12-18 | 1989-09-14 | Mayr Christian Gmbh & Co Kg | SLIP RINGLESS, ELECTROMAGNETIC OVERLOAD CLUTCH |
| KR100242671B1 (en) | 1991-03-07 | 2000-03-02 | 고돈 에릭 | Genetically engineered vaccine strain |
| EP0826063A1 (en) | 1995-04-25 | 1998-03-04 | Vical Incorporated | Single-vial formulations of dna/lipid complexes |
| US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
| FR2751228B1 (en) | 1996-07-19 | 1998-11-20 | Rhone Merieux | BOVINE POLYNUCLEOTIDE VACCINE FOR INTRADERMAL ROUTE |
| FR2751224B1 (en) | 1996-07-19 | 1998-11-20 | Rhone Merieux | POLYNUCLEOTIDE VACCINE FORMULA AGAINST BREATHING AND PIG REPRODUCTIVE CONDITIONS |
| FR2751227B1 (en) | 1996-07-19 | 1998-11-27 | Rhone Merieux | POLYNUCLEOTIDE VACCINE FORMULA AGAINST CANINE CONDITIONS, ESPECIALLY RESPIRATORY AND DIGESTIVE CONDITIONS |
| FR2751226B1 (en) | 1996-07-19 | 1998-11-27 | Rhone Merieux | POLYNUCLEOTIDE VACCINE FORMULA AGAINST HORSE PATHOLOGIES |
| FR2751229B1 (en) | 1996-07-19 | 1998-11-27 | Rhone Merieux | POLYNUCLEOTIDE VACCINE FORMULA IN PARTICULAR AGAINST RESPIRATORY PATHOLOGY OF CATTLE |
| FR2751225B1 (en) | 1996-07-19 | 1998-11-27 | Rhone Merieux | AVIAN POLYNUCLEOTIDE VACCINE FORMULA |
| ES2241042T3 (en) | 1996-10-11 | 2005-10-16 | The Regents Of The University Of California | IMMUNO STIMULATOR POLINUCLEOTIDE CONJUGATES / IMMUNOMODULATOR MOLECULA. |
| CZ299473B6 (en) | 1997-06-30 | 2008-08-06 | Rhone-Poulenc Rorer S. A. | Nucleic acid and electric field as associated product for transfer of nucleic acid into cells of adversely stripped musculature |
| FR2778858B1 (en) | 1998-05-20 | 2000-06-16 | Oreal | STABLE W / O / W EMULSION AND ITS USE AS A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION |
| FR2801607B1 (en) | 1999-11-26 | 2001-12-28 | Merial Sas | DUCK TIRES AND CORRESPONDING VACCINES |
| US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
| NZ545289A (en) | 2003-07-24 | 2008-05-30 | Merial Ltd | Vaccine formulations comprising an oil-in-water emulsion |
| US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
| EP2062594A1 (en) * | 2007-11-21 | 2009-05-27 | Wyeth Farma, S.A. | Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same |
| MX2010005701A (en) * | 2007-11-26 | 2010-08-31 | London School Of Hygiene & Tro | Method for producing vaccinal viral strain of a virus of the reoviridae family. |
-
2013
- 2013-06-13 MA MA37749A patent/MA37749B1/en unknown
- 2013-06-13 CN CN201380038286.6A patent/CN104582724A/en active Pending
- 2013-06-13 JP JP2015517428A patent/JP6347257B2/en active Active
- 2013-06-13 KR KR1020157000827A patent/KR102136437B1/en active IP Right Grant
- 2013-06-13 AU AU2013274191A patent/AU2013274191B2/en active Active
- 2013-06-13 ES ES13766730.9T patent/ES2664069T3/en active Active
- 2013-06-13 NZ NZ703297A patent/NZ703297A/en unknown
- 2013-06-13 WO PCT/US2013/045667 patent/WO2013188673A2/en active Application Filing
- 2013-06-13 US US13/917,259 patent/US10801039B2/en active Active
- 2013-06-13 CA CA2876196A patent/CA2876196C/en active Active
- 2013-06-13 CN CN201910804847.8A patent/CN110628822A/en active Pending
- 2013-06-13 BR BR112014031133-1A patent/BR112014031133B1/en active IP Right Grant
- 2013-06-13 RU RU2015100269A patent/RU2656187C2/en active
- 2013-06-13 MX MX2014015311A patent/MX364875B/en active IP Right Grant
- 2013-06-13 EP EP13766730.9A patent/EP2861248B1/en active Active
-
2014
- 2014-12-09 IL IL236148A patent/IL236148B/en active IP Right Grant
- 2014-12-11 ZA ZA2014/09124A patent/ZA201409124B/en unknown
- 2014-12-12 TN TN2014000518A patent/TN2014000518A1/en unknown
-
2015
- 2015-10-14 HK HK15110020.6A patent/HK1209326A1/en unknown
-
2016
- 2016-10-03 AU AU2016235036A patent/AU2016235036A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150036057A (en) | 2015-04-07 |
| MX2014015311A (en) | 2016-04-04 |
| JP2015525076A (en) | 2015-09-03 |
| RU2015100269A (en) | 2016-08-10 |
| MX364875B (en) | 2019-05-09 |
| AU2013274191A1 (en) | 2015-01-22 |
| CA2876196A1 (en) | 2013-12-19 |
| WO2013188673A2 (en) | 2013-12-19 |
| EP2861248A2 (en) | 2015-04-22 |
| CN110628822A (en) | 2019-12-31 |
| MA37749A1 (en) | 2016-08-31 |
| BR112014031133A2 (en) | 2017-08-15 |
| JP6347257B2 (en) | 2018-06-27 |
| TN2014000518A1 (en) | 2016-03-30 |
| AU2013274191B2 (en) | 2016-09-22 |
| AU2016235036A1 (en) | 2016-10-27 |
| CA2876196C (en) | 2021-09-21 |
| NZ703297A (en) | 2016-04-29 |
| MA37749B1 (en) | 2017-05-31 |
| KR102136437B1 (en) | 2020-07-21 |
| ES2664069T3 (en) | 2018-04-18 |
| CN104582724A (en) | 2015-04-29 |
| US20130337010A1 (en) | 2013-12-19 |
| RU2656187C2 (en) | 2018-05-31 |
| WO2013188673A3 (en) | 2014-03-27 |
| HK1209326A1 (en) | 2016-04-01 |
| IL236148A0 (en) | 2015-01-29 |
| EP2861248B1 (en) | 2017-11-15 |
| IL236148B (en) | 2019-05-30 |
| BR112014031133B1 (en) | 2023-02-07 |
| US10801039B2 (en) | 2020-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1207967A1 (en) | Vaccine | |
| HK1209413A1 (en) | Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof 5--2- | |
| HK1202545A1 (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
| HK1203493A1 (en) | Substituted azabicycles and use thereof | |
| HK1210949A1 (en) | Combinations and uses thereof | |
| ZA201409124B (en) | Reassortant btv and ahsv vaccines | |
| EP2876161A4 (en) | Vaccine | |
| GB201223386D0 (en) | Vaccine | |
| HK1203198A1 (en) | Substituted phenylimidazopyrazoles and use thereof | |
| HK1210809A1 (en) | Beta-hexosyl-transferases and uses thereof | |
| GB201301571D0 (en) | Product and use | |
| EP2822599A4 (en) | Vaccine formulation | |
| PL2911688T3 (en) | Cross-protecting salmonella vaccines | |
| HK1207154A1 (en) | C1q-adiponectin complex and use thereof c1q- | |
| GB201202090D0 (en) | Vaccine | |
| GB201222541D0 (en) | Kiddibidet and pottibidet | |
| GB201217321D0 (en) | Vaccine | |
| GB201210226D0 (en) | Vaccine | |
| IL218974A0 (en) | Conaction bitwen coutch and playels | |
| GB201206169D0 (en) | Vaccine | |
| AP2015008228A0 (en) | Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof | |
| GB201205599D0 (en) | Vaccine | |
| GB201202021D0 (en) | Co-sleeper and breastfeeder | |
| GB201220504D0 (en) | Product and use thereof | |
| AU2012228V (en) | GFLEUWHMTN Leucanthemum xsuperbum |